Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Feature

March 29, 2012 – Two-year follow-up data from the pivotal PLATINUM Workhorse trial comparing the safety and ...

Home March 29, 2012
Home
News

March 29, 2012 — In the second year of an ongoing trial, the Resolute zotarolimus-eluting stent (Medtronic) achieved a ...

Home March 29, 2012
Home
Feature

March 27, 2012 — Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than ...

Home March 27, 2012
Home
News

March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege ...

Home March 20, 2012
Home
Feature | Mark Paquin

April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the ...

Home March 16, 2012
Home
News

March 16, 2012 - Depression increases the risk of death in patients who have a coronary stent implanted. After seven ...

Home March 16, 2012
Home
News

March 9, 2012 — Boston Scientific Corp. announced the launch of the Promus Element everolimus-eluting coronary stent sys ...

Home March 09, 2012
Home
News

March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...

Home March 06, 2012
Home
News

February 24, 2012 ­– The U.S. Food and Drug Administration (FDA) this week granted the first coronary stent indication ...

Home February 24, 2012
Home
Technology

February 20, 2012 — Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug ...

Home February 20, 2012
Home
News

February 6, 2012 — InspireMD Inc. announced positive clinical results for its MGuard stent from a controlled randomized ...

Home February 06, 2012
Home
News

February 6, 2012 — A medical technology company commercializing the world's first and only self-apposing stent to treat ...

Home February 06, 2012
Home
News

February 1, 2012 — Boston Scientific announced the first patient use and European market launch of the Promus Element ...

Home February 01, 2012
Home
News

January 23, 2012 – Boston Scientific Corp. said the U.S. District Court for the District of New Jersey has found all the ...

Home January 24, 2012
Home
News

January 9, 2012 – A registry that includes every patient in Sweden having percutaneous coronary intervention (PCI) found ...

Home January 09, 2012
Home
Subscribe Now